Striatal microRNA controls cocaine intake through CREB signalling

Nature

Volumn 466, Issue 7303, 2010, Pages 197-202

  Hollander, Jonathan A ^a   Im, Heh In ^a   Amelio, Antonio L ^a   Kocerha, Jannet ^a   Bali, Purva ^a   Lu, Qun ^a   Willoughby, David ^b   Wahlestedt, Claes ^a   Conkright, Michael D ^a   Kenny, Paul J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Ocean Ridge Biosciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; COCAINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MICRORNA; TRANSDUCER OF REGULATED CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG;

BIOCHEMISTRY; BIOLOGICAL UPTAKE; BRAIN; DISEASE TREATMENT; DRUG USER; ENZYME ACTIVITY; MOLECULAR ANALYSIS; PROTEIN; RNA; RODENT; SIGNALING;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; MOTIVATION; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; MALE; MAP KINASE KINASE KINASES; MICRORNAS; NEOSTRIATUM; RATS; RATS, WISTAR; REWARD; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

RATTUS;

EID: 77954510708     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature09202     Document Type: Article

References (61)

1. McClung, C. A. & Nestler, E. J. Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33, 3-17 (2008).
2. Kalivas, P. W. & O'Brien, C. P. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 33, 166-180 (2008).
3. Thomas, M. J., Kalivas, P. W. & Shaham, Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br. J. Pharmacol. 154, 327-342 (2008).
4. Pulipparacharuvil, S. et al. Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron 59, 621-633 (2008).
5. Carlezon, W. A. J. et al. Regulation of cocaine reward by CREB. Science 282, 2272-2275 (1998)
6. Anthony, J.C., Warner, L.A. & Kessler, R.C. Comparative epidemiologyofdependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 2, 244-268 (1994).
7. Ahmed, S. H. & Koob, G. F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 282, 298-300 (1998).
8. Vanderschuren, L. J. & Everitt, B. J. Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305, 1017-1019 (2004).
9. Deroche-Gamonet, V., Belin, D. & Piazza, P. V. Evidence for addiction-like behavior in the rat. Science 305, 1014-1017 (2004).
10. Paterson, N. E. & Markou, A. Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport 14, 2229-2232 (2003).
11. Belin, D., Balado, E., Piazza, P. V. & Deroche-Gamonet, V. Pattern of intake and drug craving predict the development of cocaine addiction-like behavior in rats. Biol. Psychiatry 65, 863-868 (2009).
12. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
13. Schratt, G. M. et al. A brain-specific microRNA regulates dendritic spine development. Nature 439, 283-289 (2006).
14. Wayman, G. A. et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl Acad. Sci. USA 105, 9093-9098 (2008).
15. Perkins, D. O., Jeffries, C. & Sullivan, P. Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia. Mol. Psychiatry 10, 69-78 (2005).
16. Rogaev, E. I. Small RNAs in human brain development and disorders. Biochemistry (Mosc.) 70, 1404-1407 (2005).
17. Pietrzykowski, A. Z. et al. Posttranscriptional regulation of BK channel splice variant stabilitybymiR-9underlies neuroadaptation toalcohol.Neuron 59, 274-287 (2008).
18. Chandrasekar, V. & Dreyer, J. L. microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol. Cell. Neurosci. 42, 350-362 (2009).
19. Nudelman, A. S. et al. Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus 20, 492-498 (2010).
20. Everitt, B. J. & Robbins, T. W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Neurosci. 8, 1481-1489 (2005).
21. Belin, D. & Everitt, B. J. Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 57, 432-441 (2008).
22. Ito, R., Dalley, J. W., Robbins, T. W. & Everitt, B. J. Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J. Neurosci. 22, 6247-6253 (2002).
23. Vanderschuren, L. J., Di Ciano, P. & Everitt, B. J. Involvement of the dorsal striatum in cue-controlled cocaine seeking. J. Neurosci. 25, 8665-8670 (2005).
24. Vo, N. et al. A cAMP-response element binding protein-induced microRNAregulates neuronal morphogenesis. Proc. Natl Acad. Sci. USA 102, 16426-16431 (2005).
25. Piazza, P. V., Deroche-Gamonent, V., Rouge-Pont, F. & Le Moal, M. Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction. J. Neurosci. 20, 4226-4232 (2000).
26. Kocerha, J. et al. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc. Natl Acad. Sci. USA 106, 3507-3512 (2009).
27. Elmén, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899 (2008).
28. Tsang, J., Zhu, J. & van Oudenaarden, A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol. Cell 26, 753-767 (2007).
29. McClung, C. A. & Nestler, E. J. Regulation of gene expression and cocaine reward by CREB and DFosB. Nature Neurosci. 6, 1208-1215 (2003).
30. DiNieri, J. A. et al. Altered sensitivity to rewarding and aversive drugs in mice with inducible disruption of cAMP response element-binding protein function within the nucleus accumbens. J. Neurosci. 29, 1855-1859 (2009).
31. Conkright, M. D. et al. TORCs: transducers of regulated CREB activity. Mol. Cell 12, 413-423 (2003).
32. Perry, S. J. et al. Targeting of cyclic AMP degradation to b2-adrenergic receptors by b-arrestins. Science 298, 834-836 (2002).
33. Nishi, A. et al. Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. J. Neurosci. 28, 10460-10471 (2008).
34. Liu, Y. et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456, 269-273 (2008).
35. Ding, Q. et al. Raf kinase activation of adenylyl cyclases: isoform-selective regulation. Mol. Pharmacol. 66, 921-928 (2004).
36. Beazely, M. A., Alan, J. K. & Watts, V. J. Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells. Mol. Pharmacol. 67, 250-259 (2005).
37. Duman, R. S., Tallman, J. F. & Nestler, E. J. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246, 1033-1039 (1988).
38. Varga, E. V. et al. Involvement of Raf1 in chronic d-opioid receptor agonist-mediated adenylyl cyclase superactivation. Eur. J. Pharmacol. 451, 101-102 (2002).
39. King, A. J. et al. The protein kinase Pak3 positively regulates Raf1 activity through phosphorylation of serine 338. Nature 396, 180-183 (1998).
40. Hatzivassiliou, G. et al. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature 464, 431-435 (2010).
41. Hall-Jackson, C. A. et al. Paradoxical activation of Raf by a novel Raf inhibitor. Chem. Biol. 6, 559-568 (1999).
42. Chin, P. C. et al. The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism. J. Neurochem. 90, 595-608 (2004).
43. Selbach, M. et al. Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63 (2008).
44. Baek, D. et al. The impact of microRNAs on protein output. Nature 455, 64-71 (2008).
45. Wakioka, T. et al. Spred is a Sprouty-related suppressor of Ras signalling. Nature 412, 647-651 (2001).
46. Brems, H. et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nature Genet. 39, 1120-1126 (2007).
47. Altarejos, J. Y. et al. The Creb1 coactivator Crtc1 is required for energy balance and fertility. Nature Med. 14, 1112-1117 (2008).
48. Kovacs, K. A. et al. TORC1 is a calcium-and cAMP-sensitive coincidence detector involved in hippocampal long-term synaptic plasticity. Proc. Natl Acad. Sci. USA 104, 4700-4705 (2007).
49. Zhou, Y. et al. Requirement of TORC1 for late-phase long-term potentiation in the hippocampus. PLoS ONE 1, e16, doi:10.1371/journal.pone. 0000016 (2006).
50. Li, S., Zhang, C., Takemori, H., Zhou, Y. & Xiong, Z. Q. TORC1 regulates activity-dependent CREB-target gene transcription and dendritic growth of developing cortical neurons. J. Neurosci. 29, 2334-2343 (2009).
51. Caine, B. & Koob, G. F. in Behavioural Neuroscience: A Practical Approach Vol. 2 (ed. Sahgal, A.) 117-143 (IRL, 1993).
52. Kenny, P. J. & Markou, A. Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 31, 1203-1211 (2006).
53. Ahmed, S. H. & Koob, G. F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 282, 298-300 (1998).
54. Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Coordinates 3rd edn (Academic, 1997).
55. Silahtaroglu, A. N. et al. Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nature Protocols 2, 2520-2528 (2007).
56. Amelio, A. L. et al. A coactivator trap identifies NONO (p54nrb) as a component of the cAMP-signaling pathway. Proc. Natl Acad. Sci. USA 104, 20314-20319 (2007).
57. Bondeva, T., Balla, A., Varnai, P. & Balla, T. Structural determinants of Ras-Raf interaction analyzed in live cells. Mol. Biol. Cell 13, 2323-2333 (2002).
58. Sui, G. et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl Acad. Sci. USA 99, 5515-5520 (2002).
59. Conkright, M. D. et al. TORCs: transducers of regulated CREB activity. Mol. Cell 12, 413-423 (2003).
60. Mayr, C., Hemann, M. T. & Bartel, D. P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315, 1576-1579 (2007).
61. Vasudevan, S., Tong, Y. & Steitz, J. A. Switching from repression to activation: microRNAs can up-regulate translation. Science 318, 1931-1934 (2007).